Iniciar sesión Regístrese gratis

Abeona Therapeutics Inc Margen bruto

¿Qué es el Margen bruto de Abeona Therapeutics Inc?

El Margen bruto de Abeona Therapeutics Inc es 100.00%

¿Cuál es la definición de Margen bruto?



El margen bruto es la diferencia entre el ingreso y el costo de los bienes vendidos, dividido por el ingreso y expresado como un porcentaje.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Margen bruto de compañías en Sector Health Care en NASDAQ en comparadas con Abeona Therapeutics Inc

¿Qué hace Abeona Therapeutics Inc?

abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t

Empresas con margen bruto similar a Abeona Therapeutics Inc